about
P3781
Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBVPK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant PatientsA Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver FunctionProspective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With TelbivudineEfficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B VirusEfficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B VirusA Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic ChemotherapyA Phase III Study in Post-operative HBV-related Hepatocellular CarcinomaPegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278)Phase I Study to Investigate the Safety and Efficacy of HBV DNA VaccineTelbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis BTenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus AdefovirA Two-year Study of Telbivudine in HBeAg Negative HepatitisSwitch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B PatientsLamivudine and Adefovir Dipivoxil Fixed Dose CombinationEfficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)HEPSERA Post Marketing SurveillanceDrug-Drug Interaction Study of Vadadustat With Digoxin, Adefovir and Furosemide
P4844
Deep sequencing analysis of HBV genotype shift and correlation with antiviral efficiency during adefovir dipivoxil therapyEffect of hepatitis B virus genotypes on the efficacy of adefovir dipivoxil antiviral therapy.Resistant mutants induced by adefovir dipivoxil in hepatitis B virus isolates.Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B.Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance.Optimized combination therapies with adefovir dipivoxil (ADV) and lamivudine, telbivudine, or entecavir may be effective for chronic hepatitis B patients with a suboptimal response to ADV monotherapy.Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapyDe novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine.Effect of adefovir dipivoxil on T cell immune function in the treatment of chronic hepatitis B and hepatocirrhosisAdefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection.Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: A study of 28 cases.Relationship between nephrotoxicity and long-term adefovir dipivoxil therapy for chronic hepatitis B: A meta-analysis.The curative effect of adefovir dipivoxil treating HBeAg negative chronic hepatitis B and treating HBeAg positive chronic hepatitis B combining interferon α-2b.Pathologic Femoral Neck Fracture Due to Fanconi Syndrome Induced by Adefovir Dipivoxil Therapy for Hepatitis B.[Efficacy Observation of Yiguanjian Decoction Combined Adefovir Dipivoxil Tablet in Treating HBeAg Negative Chronic Viral Hepatitis B Active Compensated Liver Cirrhosis Patients].Urinary β-2 Microglobulin Levels Sensitively Altered in an Osteomalacia Patient Receiving Add-on Adefovir Dipivoxil Therapy for Hepatitis B Virus Infection.Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis.Application of ionic liquid to polymorphic transformation of anti-viral/HIV drug adefovir dipivoxil.[Adefovir dipivoxil effects on and related factors of blood phosphorus metabolism in patients with chronic hepatitis B].Mechanism study on stability enhancement of adefovir dipivoxil by cocrystallization: Degradation kinetics and structure-stability correlation.Osteomalacia induced by long-term low-dose adefovir dipivoxil: Clinical characteristics and genetic predictors.Adefovir dipivoxil. Bis-POM PMEA, GS 0840, GS 840, Piv2PMEAAdefovir dipivoxil. Bis-POM PMEA, GS 0840, GS 840, Piv2PMEA[Clinical analysis of Fanconi syndrome induced by adefovir dipivoxil]
P921
Q61914442-188ADD4F-1B84-4C1A-A0D7-CCDC61BDF52DQ61914496-D12C60BA-C0E0-4C91-9502-33D4630DADA6Q61914858-7675871A-9A67-4001-B485-1DB3DDBC5657Q61914910-B721E18B-D2D1-4C00-A04A-4F11E12E707AQ61917509-94576A4A-8AD6-43D5-8749-F4343298683FQ61917524-3FA8FB99-5C56-4E66-A9B0-432E22361E36Q61918171-FC159F27-0830-4846-B1D5-BD02E5E0FBEAQ61920658-A63C7144-789E-4CEC-A6B8-1958A4E047FEQ61933098-31810407-D470-46E1-8E27-97A849E41C5DQ61978921-A3DFAAC5-B8C2-4F82-BFCA-443642F0D938Q62104783-E03F6CA3-7E22-4EE0-9E4B-8A83447D6BDEQ63011202-E0B4F7BD-985A-4671-93F1-5B6C7DC25B57Q63319933-C9F79A65-09BF-4892-9720-870B6E003D33Q63320564-AA3A9208-9BEE-4962-AD7F-71447E2C6E84Q63337800-00D91FA1-6845-4926-A0D3-3FF0223BD3C1Q63338241-4CBAFF87-A738-46FB-8373-9958DF1877B0Q63338288-5E4F8E21-E0AA-4F91-AF88-C633D5D99AB7Q63591472-3C3D16A8-47D9-467C-A363-820BE4B3B395
P4844
Q28545779-5C64472A-E2E2-4CD5-A8F7-EE37E56D17A9Q34196714-76D29201-3397-4721-B2BA-C0E662589B6FQ34647599-89F0A203-6146-4AD2-B98E-E6D02E2D9F7DQ35221837-BAF2840A-C416-42C9-8AB0-E015DEB147ECQ35694422-31AF1E73-9272-46A8-8D44-EF2F8ECA4C50Q36492959-362A7EA8-914A-4816-9651-B531649C36F0Q36502057-40C1D7EA-D738-4746-ACEF-1B62B3ED6921Q36800501-C5F385F8-4CBE-4423-A442-3775E9AAF8B0Q37288061-5E378162-D27A-4155-BB40-64D48EE0A214Q37413142-52C75FD3-A041-40FA-A663-1A31EDA1C75BQ37593985-8DC87FE0-A3F4-479B-A318-56D8CC96753DQ37608351-98F90503-F165-48AE-8BAC-E18743C4CC25Q40473014-B7FD901F-8F45-48BD-8414-08F1E8606C5EQ40650531-C398AB67-5250-415D-857E-0E79114C55FFQ40663810-E812A392-905D-410C-BD30-FB029F2FC960Q40701421-F85D4226-EC4A-4D43-A8E7-001E0E5DC3D3Q40835453-361AFA97-8379-413A-B773-1D4DD734A185Q40892139-562F6493-95D4-418D-8FCB-61C28856745BQ40961705-9D91D467-A402-4765-9BC4-A187419D8B52Q47903019-0BDCB12A-559C-4B37-BCFB-C35CEDA8C070Q51467080-C1A968D5-29E2-40D7-8490-5A72524FF3C8Q73573842-5F946E41-6317-4960-B49F-EB7F65207DB9Q74415291-1B42D48F-A880-45A9-9956-AB1E58F1328FQ86351178-BCCD9859-1CEB-40FA-9D1E-BE05C320D0A5
P921
description
chemical compound
@en
komponim kimik
@sq
քիմիական միացություն
@hy
مركب كيميائي
@ar
name
Adefovir-Dipivoxil
@de
adefovir dipivoxil
@en
type
label
Adefovir-Dipivoxil
@de
adefovir dipivoxil
@en
altLabel
((2-(6-amino-9h-purin-9-yl)eth ...... er with hydroxymethyl pivalate
@en
9-(2-((bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine
@en
adefovir di(pivaloyloxymethyl) ester
@en
adefovir pivoxil
@en
gs-0840
@en
propanoic acid, 2,2-dimethyl-, ...... lidene)bis(oxymethylene) ester
@en
prefLabel
Adefovir-Dipivoxil
@de
adefovir dipivoxil
@en
P486
P683
P1748
P2115
N0000148776
P231
142340-99-6
P232
P235
WOZSCQDILHKSGG-UHFFFAOYSA-N
P2566
100.162.308
P267
P3117
DTXSID5046487
P3345
P3780
P486
P4964
splash10-00b9-0291650000-bfacc10ec3119e8320f0
P652
U6Q8Z01514